Navigation Links
Abbott to Subsidize Price of HIV Drug

The US-based pharmaceutical multi-national, the Abbott, has agreed to lower the prices of Kaletra/Aluvia in low and low-middle income countries to one thousand// US dollars, on a request from the World Health Organization’s Director-General Margaret Chan.

Kaletra is indicated for the treatment of HIV-1 infected adults and children above the age of 2 years, in combination with other antiretroviral agents. It is in a category of HIV medicines called protease inhibitors (PIs).

Protease is a chemical, known as an enzyme that HIV needs in order to make new viruses. Protease inhibitors (PIs) block the protease enzyme. When protease is blocked, HIV makes copies of itself that cannot infect new cells.

Kaletra is actually two drugs combined into a single capsule: lopinavir and low doses of ritonavir, another protease inhibitor manufactured by Abbott Laboratories.

In some parts of the world, these Kaletra tablets are sold under the brand name Aluvia.

To meet the needs of countries committed to expanding HIV/AIDS treatment, Abbott will offer the governments of more than 40 low and low-middle income countries (as defined by World Bank criteria) and NGOs a new price of $1,000 per patient per year.

This price is lower than any generic price available in the world today for this medicine and is approximately 55 percent less than the average current price for these countries, the press release states.

Abbott will immediately begin discussions with individual countries where Abbott's patents are respected to maximize the number of patients that can be provided Kaletra/Aluvia capsules and tablets at this new price.

At the same time the Abbott affirmed that the patents of scientists and inventors must exist so that there were incentives for sustained research and development. Without this system, the miracle drugs the world enjoys today, including HIV medicines, would not exist, it said.

Specifically, with regard to Thailand, Abbott appreciated and fully respected the suggestion of Director-General Chan that more work needed to be done with the government of Thailand to achieve a positive outcome. Meanwhile, Kaletra capsules would be in Thailand and eligible for the new price.

Today, Kaletra capsules are registered in 118 countries.
GPL/B
'"/>




Related medicine news :

1. Pharmacia may take 51.5 percent Abbott stake
2. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
3. Abbott’s Laboratories R&D Capabilities Questione
4. Abbott Receives CE Mark Certification
5. Abbott Offers Aluvia to Thailand in Return for Compulsory Licensing Halt
6. Herceptin Subsidized By Australian Government
7. Cervical Cancer Vaccine Gardasil Included In Subsidized CDC program
8. Drug Prices in India to be Monitored - NPPA to Tie up with ORG
9. Price Of Alcohol Does Not Influence Consumption
10. Delhi Sees Sharp Decline In Chicken Prices
11. Prices of eggs, egging its way upwards
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... ... , ... Planet Fitness, one of the largest and fastest growing franchisors and ... flagship location in Covington, LA at 401 N. U.S. Highway 190, in January of ... Depot in the Holiday Square shopping center. Its location allows it to serve both ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in property taxes a year. In some states—like New York, New Jersey, Massachusetts, ... contrast, many overseas retirement havens have extremely low property-tax rates, which contributes to ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: